ClinicalTrials.Veeva

Menu

A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Performance and Safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive Dressings in the Management of Surgical and Traumatic Wounds (MATILDA)

Convatec logo

Convatec

Status

Completed

Conditions

Surgical Wound
Trauma-related Wound

Treatments

Device: ConvaFoam

Study type

Interventional

Funder types

Industry

Identifiers

NCT05632276
WC-22-440

Details and patient eligibility

About

A prospective, multi centre, interventional, non-comparator, open label study to demonstrate the efficacy, performance and safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive dressings in the management of surgical and traumatic wounds

Full description

A prospective, multi centre, interventional, non-comparator, open label study to demonstrate the efficacy, performance and safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive dressings in the management of surgical and traumatic wounds for up to 4 weeks

Enrollment

54 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years and over
  • Patients able and willing to provide informed consent
  • Patients with Surgical wounds including incisional wounds including laparoscopic
  • wounds and surgical wounds healing by secondary intention.
  • Patients with Traumatic wounds
  • Patients must be willing to attend visits as per schedule in protocol

Exclusion criteria

  • Patients with known allergies to any of the materials used in the dressing
  • Patients who require any oxidising agents such as hydrogen peroxide or hypochlorite solutions.
  • Patients, who in the opinion of the investigator, is considered unsuitable for any other reason
  • Patients with wounds showing signs of infection on presentation or not resolving with the use of antibiotics

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

54 participants in 1 patient group

ConvaFoam dressings
Other group
Description:
Participants wounds will be assessed and will be allocated ConvaFoam Border, Silicone or Non-Adhesive dressing based upon the investigator's clinical judgment. participants will receive a dressing as part of a protocol of care for up to a period of 4 weeks
Treatment:
Device: ConvaFoam

Trial contacts and locations

2

Loading...

Central trial contact

Sally Kaplan; Alisha Oropallo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems